News
INO
1.840
-0.27%
-0.005
Investors Looking To Durable Goods, New-Home Sales Data As Earnings Season Winds Down
Seeking Alpha · 1d ago
Catalyst Watch: Labor pains for Amazon & Starbucks, Nasdaq call-up for MicroStrategy and Pony AI ratings
Seeking Alpha · 2d ago
Weekly Report: what happened at INO last week (1209-1213)?
Weekly Report · 6d ago
Inovio Pharmaceuticals: The Dangerous Allure Of A Falling Knife
Seeking Alpha · 12/15 12:00
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 12/13 21:06
Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet
Benzinga · 12/13 19:10
Inovio Pharmaceuticals Shares Touch 52-Week Low After $30M Offering
Dow Jones · 12/13 18:11
US Stocks Mixed; Broadcom Shares Surge On Upbeat Earnings
Benzinga · 12/13 15:39
Why Inovio Pharmaceuticals (INO) Stock Is Down 40%
Benzinga · 12/13 15:38
Morning Movers: Penn Entertainment rises following upgrade
TipRanks · 12/13 14:00
BUZZ-Inovio Pharma plumbs new lows on stock-and-warrants offering
Reuters · 12/13 13:31
Inovio 10M share Spot Secondary priced at $3.00
TipRanks · 12/13 12:30
INOVIO stock slides after pricing $30M equity offering
Seeking Alpha · 12/13 12:27
INOVIO PHARMACEUTICALS INC SAYS PRICING OF UNDERWRITTEN PUBLIC OFFERING OF 10 MLN SHARES
Reuters · 12/13 12:00
US Stocks Likely To Open Higher, Investors Eye Fed Policy Meet Next Week: Broadcom, RH, Costco In Focus
Benzinga · 12/13 11:55
Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Benzinga · 12/13 10:30
RH, Broadcom And 3 Stocks To Watch Heading Into Friday
Benzinga · 12/13 06:56
Inovio Down 20% After Hours on Planned Stock and Warrant Sale
Dow Jones · 12/12 23:49
BUZZ-Inovio Pharma tumbles on planned stock offering
Reuters · 12/12 21:27
INOVIO Pharmaceuticals announces proposed public offering
Seeking Alpha · 12/12 21:11
More
Webull provides a variety of real-time INO stock news. You can receive the latest news about Inovio Pharmaceu through multiple platforms. This information may help you make smarter investment decisions.
About INO
Inovio Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing deoxyribonucleic acid (DNA) medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines pipeline include INO-3107 for HPV-related recurrent respiratory papillomatosis (RRP); INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma, or OPSCC; VGX-3100 for the treatment of Anal or Perianal HSIL; INO-5401 for the treatment of Glioblastoma Multiforme (GBM), and INO-5401 for the Treatment of Glioblastoma Multiforme (GBM). Its lead candidate is INO-3107 for the treatment of RRP, a rare and debilitating disease of the respiratory tract caused by HPV infection. Its DNA medicines platform consists of DNA plasmids and its CELLECTRA devices, which are used to deliver the DNA plasmids into the cell. Its CELLECTRA device portfolio consists of two models.